The meta-analysis of existing evidence implies an active role for Lp(a) in the initiation and progression of CAVD, with increased mortality and risk for serious adverse outcomes associated with higher Lp(a) levels. Here, LPA is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.